Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1968
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 4
1969 3
1970 2
1971 4
1972 4
1973 1
1974 5
1975 6
1976 4
1977 4
1978 3
1979 4
1980 5
1981 1
1982 4
1983 3
1984 11
1985 13
1986 4
1987 15
1988 14
1989 23
1990 18
1991 29
1992 34
1993 27
1994 50
1995 34
1996 30
1997 37
1998 56
1999 43
2000 46
2001 58
2002 32
2003 78
2004 58
2005 84
2006 108
2007 97
2008 114
2009 187
2010 181
2011 230
2012 245
2013 241
2014 294
2015 335
2016 328
2017 386
2018 354
2019 335
2020 507
2021 581
2022 508
2023 444
2024 500
2025 37

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

6,173 results

Results by year

Filters applied: . Clear all
Page 1
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.
Schaff LR, Mellinghoff IK. Schaff LR, et al. JAMA. 2023 Feb 21;329(7):574-587. doi: 10.1001/jama.2023.0023. JAMA. 2023. PMID: 36809318 Free PMC article. Review.
OBSERVATIONS: Approximately 49% of malignant brain tumors are glioblastomas, and 30% are diffusely infiltrating lower-grade gliomas. Other malignant brain tumors include primary central nervous system (CNS) lymphoma (7%) and malignant forms of ependymomas (3%) and meningio …
OBSERVATIONS: Approximately 49% of malignant brain tumors are glioblastomas, and 30% are diffusely infiltrating lower-grade gliomas. …
Glioblastoma and other malignant gliomas: a clinical review.
Omuro A, DeAngelis LM. Omuro A, et al. JAMA. 2013 Nov 6;310(17):1842-50. doi: 10.1001/jama.2013.280319. JAMA. 2013. PMID: 24193082 Review.
IMPORTANCE: Glioblastomas and malignant gliomas are the most common primary malignant brain tumors, with an annual incidence of 5.26 per 100,000 population or 17,000 new diagnoses per year. ...EVIDENCE REVIEW: Search of PubMed references from January 2000 to May 2013 using …
IMPORTANCE: Glioblastomas and malignant gliomas are the most common primary malignant brain tumors, with an annual incidence of 5.26 …
Glioblastoma.
Wirsching HG, Galanis E, Weller M. Wirsching HG, et al. Handb Clin Neurol. 2016;134:381-97. doi: 10.1016/B978-0-12-802997-8.00023-2. Handb Clin Neurol. 2016. PMID: 26948367 Review.
The classic clinical term "secondary glioblastoma" refers to a minority of glioblastomas that evolve from previously diagnosed WHO grade II or grade III gliomas. Specific point mutations of the genes encoding isocitrate dehydrogenase (IDH) 1 or 2 appear to define mo …
The classic clinical term "secondary glioblastoma" refers to a minority of glioblastomas that evolve from previously diagnosed …
Molecular targeted therapy of glioblastoma.
Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, Reifenberger G, Weller M. Le Rhun E, et al. Cancer Treat Rev. 2019 Nov;80:101896. doi: 10.1016/j.ctrv.2019.101896. Epub 2019 Sep 11. Cancer Treat Rev. 2019. PMID: 31541850 Free article. Review.
Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH)-wildtype tumors. Incidence increases with age, males are more often affected. ...
Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or progenitor cells. More than 90% of glioblast
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, Horbinski C, Huang RY, Lassman AB, Le Rhun E, Lim M, Mehta MP, Mellinghoff IK, Minniti G, Nathanson D, Platten M, Preusser M, Roth P, Sanson M, Schiff D, Short SC, Taphoorn MJB, Tonn JC, Tsang J, Verhaak RGW, von Deimling A, Wick W, Zadeh G, Reardon DA, Aldape KD, van den Bent MJ. Wen PY, et al. Neuro Oncol. 2020 Aug 17;22(8):1073-1113. doi: 10.1093/neuonc/noaa106. Neuro Oncol. 2020. PMID: 32328653 Free PMC article. Review.
Glioblastomas are the most common form of malignant primary brain tumor and an important cause of morbidity and mortality. ...In this consensus review from the Society for Neuro-Oncology (SNO) and the European Association of Neuro-Oncology (EANO), the current management of
Glioblastomas are the most common form of malignant primary brain tumor and an important cause of morbidity and mortality. ...In this
Glioblastoma: Overview of Disease and Treatment.
Davis ME. Davis ME. Clin J Oncol Nurs. 2016 Oct 1;20(5 Suppl):S2-8. doi: 10.1188/16.CJON.S1.2-8. Clin J Oncol Nurs. 2016. PMID: 27668386 Free PMC article. Review.
BACKGROUND: Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. Current treatment options at diagnosis are multimodal and include surgical resection, radiation, and chemotherapy. ...
BACKGROUND: Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. Current treatment options at diagno …
Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques.
Czarnywojtek A, Borowska M, Dyrka K, Van Gool S, Sawicka-Gutaj N, Moskal J, Kościński J, Graczyk P, Hałas T, Lewandowska AM, Czepczyński R, Ruchała M. Czarnywojtek A, et al. Pharmacology. 2023;108(5):423-431. doi: 10.1159/000531319. Epub 2023 Jul 17. Pharmacology. 2023. PMID: 37459849 Free article. Review.
BACKGROUND: Glioblastoma multiforme (GBM) is a WHO grade 4 glioma and the most common malignant primary brain tumour. ...
BACKGROUND: Glioblastoma multiforme (GBM) is a WHO grade 4 glioma and the most common malignant primary brain tumour. ...
Multidimensional communication in the microenvirons of glioblastoma.
Broekman ML, Maas SLN, Abels ER, Mempel TR, Krichevsky AM, Breakefield XO. Broekman ML, et al. Nat Rev Neurol. 2018 Aug;14(8):482-495. doi: 10.1038/s41582-018-0025-8. Nat Rev Neurol. 2018. PMID: 29985475 Free PMC article. Review.
An important component of glioblastoma growth is communication with and manipulation of other cells in the brain environs, which supports tumour progression and resistance to therapy. Glioblastoma cells recruit innate immune cells and change their phenotype to suppo …
An important component of glioblastoma growth is communication with and manipulation of other cells in the brain environs, which supp …
A comprehensive profile of recurrent glioblastoma.
Campos B, Olsen LR, Urup T, Poulsen HS. Campos B, et al. Oncogene. 2016 Nov 10;35(45):5819-5825. doi: 10.1038/onc.2016.85. Epub 2016 Apr 4. Oncogene. 2016. PMID: 27041580 Review.
Many therapeutic agents are first tested in clinical trials involving recurrent glioblastomas. Remarkably, however, fundamental knowledge on the biology of recurrent glioblastoma is just slowly emerging. ...We conclude that the ability to characterize and predict th …
Many therapeutic agents are first tested in clinical trials involving recurrent glioblastomas. Remarkably, however, fundamental knowl …
6,173 results